APA

Grievink H. W., Heuberger J. A. A. C., Huang F., Chaudhary R., Birkhoff W. A. J., Tonn G. R., Mosesova S., Erickson R., Moerland M., Haddick P. C. G., Scearce-Levie K., Ho C. & Groeneveld G. J. (20201112). DNL104, a Centrally Penetrant RIPK1 Inhibitor, Inhibits RIP1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers. : Clinical pharmacology and therapeutics.

Chicago

Grievink Hendrika W, Heuberger Jules A A C, Huang Fen, Chaudhary Rinkal, Birkhoff Willem A J, Tonn George R, Mosesova Sofia, Erickson Rebecca, Moerland Matthijs, Haddick Patrick C G, Scearce-Levie Kimberly, Ho Carole and Groeneveld Geert Jan. 20201112. DNL104, a Centrally Penetrant RIPK1 Inhibitor, Inhibits RIP1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers. : Clinical pharmacology and therapeutics.

Harvard

Grievink H. W., Heuberger J. A. A. C., Huang F., Chaudhary R., Birkhoff W. A. J., Tonn G. R., Mosesova S., Erickson R., Moerland M., Haddick P. C. G., Scearce-Levie K., Ho C. and Groeneveld G. J. (20201112). DNL104, a Centrally Penetrant RIPK1 Inhibitor, Inhibits RIP1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers. : Clinical pharmacology and therapeutics.

MLA

Grievink Hendrika W, Heuberger Jules A A C, Huang Fen, Chaudhary Rinkal, Birkhoff Willem A J, Tonn George R, Mosesova Sofia, Erickson Rebecca, Moerland Matthijs, Haddick Patrick C G, Scearce-Levie Kimberly, Ho Carole and Groeneveld Geert Jan. DNL104, a Centrally Penetrant RIPK1 Inhibitor, Inhibits RIP1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers. : Clinical pharmacology and therapeutics. 20201112.